IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Salix Pharmaceuticals Inc

CUSIP: 795435906 | 9 institutional holders

Quarters

Q1 2015Q4 2014Q3 2014Q2 2014Q1 2014
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile